Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
ProQuest Investments IV, L.P.
10% owner at UroGen Pharma. Filing since 27 Nov 2017.
CIK 0001431818
Company
Date
Role
Action
Shares
Amount
Of holding
URGN
UroGen Pharma Ltd.
28 Nov 2017
10% owner
Sold, plan not stated
177,807
$7.20M
12.5%
URGN
UroGen Pharma Ltd.
27 Nov 2017
10% owner
Sold, plan not stated
31,491
$1.29M
2.2%
2 decisions on file.